Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Torres

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Plos One|April 6, 2022
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of lifeMarta Carol, Martina Pérez-Guasch, Elsa Solà, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI studyTeresa Gómez-Isla, Rafael Blesa, Merce Boada, et al.
Lancet (London, England)|March 27, 2019
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Plos One|March 3, 2012
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trialRosa Solà, Rosa M Valls, Gemma Godàs, et al.
The Lancet. Neurology|April 8, 2014
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trialAngel Chamorro, Sergio Amaro, Mar Castellanos, et al.
Kidney International|September 10, 2015
Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body sizeAndrew Davenport, Sanne A E Peters, Michiel L Bots, et al.
Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2015
Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trialsSanne A E Peters, Michiel L Bots, Bernard Canaud, et al.
Journal of Hepatology|April 17, 2020
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosisEdilmar Alvarado-Tapias, Alba Ardevol, Marta Garcia-Guix, et al.
Journal of Lipid Research|September 18, 2025
Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantationAnna Baulies, Sandra Torres, Raquel Fucho, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Plos One|April 6, 2022
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of lifeMarta Carol, Martina Pérez-Guasch, Elsa Solà, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI studyTeresa Gómez-Isla, Rafael Blesa, Merce Boada, et al.
Lancet (London, England)|March 27, 2019
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Plos One|March 3, 2012
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trialRosa Solà, Rosa M Valls, Gemma Godàs, et al.
The Lancet. Neurology|April 8, 2014
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trialAngel Chamorro, Sergio Amaro, Mar Castellanos, et al.
Kidney International|September 10, 2015
Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body sizeAndrew Davenport, Sanne A E Peters, Michiel L Bots, et al.
Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2015
Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trialsSanne A E Peters, Michiel L Bots, Bernard Canaud, et al.
Journal of Hepatology|April 17, 2020
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosisEdilmar Alvarado-Tapias, Alba Ardevol, Marta Garcia-Guix, et al.
Journal of Lipid Research|September 18, 2025
Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantationAnna Baulies, Sandra Torres, Raquel Fucho, et al.
Pageof 18